Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.

[1]  R. Hawkes,et al.  ENHANCEMENT OF THE INFECTIVITY OF ARBOVIRUSES BY SPECIFIC ANTISERA PRODUCED IN DOMESTIC FOWLS. , 1964, The Australian journal of experimental biology and medical science.

[2]  S. Halstead,et al.  Immune enhancement of viral infection. , 1982, Progress in allergy.

[3]  S. Halstead,et al.  Pathogenesis of dengue: challenges to molecular biology. , 1988, Science.

[4]  S. Harrison,et al.  The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution , 1995, Nature.

[5]  M. Bray,et al.  Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge , 1996, Journal of virology.

[6]  P. Hobart,et al.  Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. , 1997, Vaccine.

[7]  K. Porter,et al.  Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques. , 2000, The Journal of general virology.

[8]  E. Konishi,et al.  A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice. , 2000, Vaccine.

[9]  C. Mandl,et al.  Attenuation of Tick-Borne Encephalitis Virus by Structure-Based Site-Specific Mutagenesis of a Putative Flavivirus Receptor Binding Site , 2000, Journal of Virology.

[10]  K. Porter,et al.  Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein. , 2000, Vaccine.

[11]  J. Roehrig,et al.  Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells , 2001, Journal of Virology.

[12]  M. Ramanathan,et al.  Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999). , 2001, The Journal of infectious diseases.

[13]  C. Mandl,et al.  Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E , 2001, Journal of Virology.

[14]  M. Ramanathan,et al.  Induction of Inflammation by West Nile virus Capsid through the Caspase-9 Apoptotic Pathway , 2002, Emerging infectious diseases.

[15]  D. Gubler.  Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. , 2002, Trends in microbiology.

[16]  D. Vaughn,et al.  Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine. , 2003, The American journal of tropical medicine and hygiene.

[17]  S. Swaminathan,et al.  Replication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2 , 2003, Journal of Virology.

[18]  R. Edelman,et al.  Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates. , 2003, The American journal of tropical medicine and hygiene.

[19]  C. Huang,et al.  Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development , 2003, Journal of Virology.

[20]  Suh-Chin Wu,et al.  A Functional Epitope Determinant on Domain III of the Japanese Encephalitis Virus Envelope Protein Interacted with Neutralizing-Antibody Combining Sites , 2003, Journal of Virology.

[21]  J. Schlesinger,et al.  Yellow Fever Virus/Dengue-2 Virus and Yellow Fever Virus/Dengue-4 Virus Chimeras: Biological Characterization, Immunogenicity, and Protection against Dengue Encephalitis in the Mouse Model , 2003, Journal of Virology.

[22]  H. Whittle,et al.  Prevalence of Neutralizing Antibodies to Adenoviral Serotypes 5 and 35 in the Adult Populations of The Gambia, South Africa, and the United States , 2004, Clinical Diagnostic Laboratory Immunology.

[23]  T. Waldmann,et al.  Coimmunization with an Optimized IL-15 Plasmid Results in Enhanced Function and Longevity of CD8 T Cells That Are Partially Independent of CD4 T Cell Help3 , 2005, The Journal of Immunology.

[24]  J. Lang,et al.  Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults. , 2006, Vaccine.

[25]  E. Konishi,et al.  Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice. , 2006, Vaccine.

[26]  Charles M. Rice,et al.  Flaviviridae :T he Viruses and Their Replication , 2007 .

[27]  Qianjun Li,et al.  The SARS-CoV ferret model in an infection–challenge study , 2008, Virology.

[28]  D. Weiner,et al.  Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. , 2008, Vaccine.

[29]  B. Korber,et al.  Expression and evolutionary analysis of West Nile virus (Merion Strain) , 2005, Journal of NeuroVirology.